MXCT Stock Price - MaxCyte, Inc. logo

MXCT Stock Price

MaxCyte, Inc.

$1.37
+$0.09(+7.03%)
37
Overall
60
Value
20
Tech
31
Quality
How is this score calculated?
Market Cap
$141.45M
Volume
1.11M
52W Range
$0.64 - $1.81
Target Price
$4.67

MXCT stock price is $1.37 (+7.03% on the day), giving MaxCyte, Inc. a market cap of $141.45M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.

MXCT Stock Overview

Price
$1.37
Previous close
$1.28
Open
$1.29
Market cap
$141.45M
52-week range
$0.64 - $1.80
1-year price target
$4.67
Sector
Healthcare
Industry
Medical - Devices
Exchange
Nasdaq
MarketXLS Rank
37

About MaxCyte, Inc.

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

ABCD
1SymbolPriceChangeVol
2MXCT$1.37+7.0%1.11M
3
4
5
6

Get MaxCyte, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.